5-에틸-1,3,4-옥사디아졸-2-일라민
|
|
5-에틸-1,3,4-옥사디아졸-2-일라민 속성
- 녹는점
- 180-181 °C
- 끓는 점
- 235.3±23.0 °C(Predicted)
- 밀도
- 1.206±0.06 g/cm3(Predicted)
- 산도 계수 (pKa)
- -0.40±0.13(Predicted)
안전
- 위험 및 안전 성명
- 위험 및 사전주의 사항 (GHS)
그림문자(GHS): | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
신호 어: | Warning | ||||||||||||||||||||||||||||
유해·위험 문구: |
|
||||||||||||||||||||||||||||
예방조치문구: |
|
5-에틸-1,3,4-옥사디아졸-2-일라민 C화학적 특성, 용도, 생산
용도
5-Ethyl-1,3,4-oxadiazol-2-amine is used as a reactant in the preparation of (acylimino)?thiadiazoline derivatives as angiotensin II receptor antagonists.5-에틸-1,3,4-옥사디아졸-2-일라민 준비 용품 및 원자재
원자재
준비 용품
5-에틸-1,3,4-옥사디아졸-2-일라민 공급 업체
글로벌( 42)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
Shaanxi Dideu Medichem Co. Ltd | +86-029-81138252 +86-18789408387 |
1057@dideu.com | China | 3958 | 58 |
CONIER CHEM AND PHARMA LIMITED | +8618523575427 |
sales@conier.com | China | 49374 | 58 |
Guangzhou Yuheng Pharmaceutical Technology Co., Ltd | +8613580539051 |
joe@yuhengpharm.com | CHINA | 21142 | 58 |
Guangzhou CATO Research Chemicals Inc. | +86-020-81960175-617 +8615602392859 |
Intermediate@cato-chem.com | China | 8056 | 58 |
Amadis Chemical Company Limited | 571-89925085 |
sales@amadischem.com | China | 131957 | 58 |
Wuhan HSN Pharmaresearch CO., LTD. | 027-63499089 18086100502 |
linwell@126.com | China | 208 | 50 |
J & K SCIENTIFIC LTD. | 010-82848833 400-666-7788 |
jkinfo@jkchemical.com | China | 96815 | 76 |
Meryer (Shanghai) Chemical Technology Co., Ltd. | 021-61259108 18621169109 |
market03@meryer.com | China | 40228 | 62 |
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd. | 025-66113011 18112977050 |
cb6@aikonchem.com | China | 16684 | 50 |
Huaian Hyperion pharmaceutical R&D Co.,Ltd. | 18114966287 |
sales@hyperionpharm.com | China | 313 | 58 |
5-에틸-1,3,4-옥사디아졸-2-일라민 관련 검색:
5-ETHYL-1,3,4-OXADIAZOL-2-YLAMINE
5-BENZYL-1,3,4-OXADIAZOL-2-YLAMINE
5-(1-(3-Pentadecylphenoxy)ethyl)-1,3,4-oxadiazol-2-amine
5-(naphthalen-1-ylmethyl)-1,3,4-oxadiazol-2-amine
3-[4-(3-CHLOROBENZOYL)-1-METHYL-1H-PYRROL-2-YL]-2-[5-(DIMETHYLAMINO)-1,3,4-OXADIAZOL-2-YL]ACRYLONITRILE
1,3,4-Oxadiazol-2-amine, 5-(1-(2,4,6-trichloro-3-pentadecylphenoxy)eth yl)-
1,3,4-Oxadiazol-2-amine, 5-(1-(4-chloro-3-pentadecylphenoxy)ethyl)-
2-[5-(DIMETHYLAMINO)-1,3,4-OXADIAZOL-2-YL]ACETONITRILE
3-(DIMETHYLAMINO)-2-[5-(DIMETHYLAMINO)-1,3,4-OXADIAZOL-2-YL]ACRYLONITRILE
5-(2-METHOXYMETHYL-THIAZOL-4-YLMETHYL)-1,3,4-OXADIAZOL-2-YLAMINE
5-(4-butylcyclohexyl)-1,3,4-oxadiazol-2-amine
5-(2-CYCLOHEXYL-THIAZOL-4-YLMETHYL)-1,3,4-OXADIAZOL-2-YLAMINE
N-cyclohexyl-5-[1-[4-(2-methylpropyl)phenyl]ethyl]-1,3,4-oxadiazol-2-a mine
2-(dipropylamino)-N-(5-ethyl-1,3,4-oxadiazol-2-yl)acetamide
FURAMIZOLE
5-[1-[4-(2-methylpropyl)phenyl]ethyl]-N-phenyl-1,3,4-oxadiazol-2-amine
5-[(3,4-dimethoxyphenyl)methyl]-1,3,4-oxadiazol-2-amine
1,3,4-Oxadiazol-2-amine, 5-(1-methyl-1-(3-pentadecylphenoxy)ethyl)-